Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in routine care - 2-year outcomes and predictors

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Pregnancy outcomes in mixed connective tissue disease: a multicentre study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Physical activity behaviour in men with inflammatory joint disease: a cross-sectional register-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. How do people with rheumatoid arthritis experience participation in a smoking cessation trial: a qualitative study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Perfusion in bone marrow lesions assessed on DCE-MRI and its association with pain in knee osteoarthritis: a cross-sectional study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. High versus standard magnetic resonance image resolution of the cervical spine in patients with axial spondyloarthritis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Objectives: A cohort of routine care RA patients in sustained remission had biological DMARD (bDMARDs) tapered according to a treatment guideline. We studied: the proportion of patients whose bDMARD could be successfully tapered or discontinued; unwanted consequences of tapering/discontinuation; and potential baseline predictors of successful tapering and discontinuation.

Methods: One-hundred-and-forty-three patients (91% receiving TNF inhibitor and 9% a non-TNF inhibitor) with sustained disease activity score (DAS28-CRP)⩽2.6 and no radiographic progression the previous year were included. bDMARD was reduced to two-thirds of standard dose at baseline, half after 16 weeks, and discontinued after 32 weeks. Patients who flared (defined as either DAS28-CRP ⩾ 2.6 and ΔDAS28-CRP ⩾ 1.2 from baseline, or erosive progression on X-ray and/or MRI) stopped tapering and were escalated to the previous dose level.

Results: One-hundred-and-forty-one patients completed 2-year follow-up. At 2 years, 87 patients (62%) had successfully tapered bDMARDs, with 26 (18%) receiving two-thirds of standard dose, 39 (28%) half dose and 22 (16%) having discontinued; and 54 patients (38%) were receiving full dose. ΔDAS28-CRP0-2yrs was 0.1((-0.2)-0.4) (median (interquartile range)) and mean ΔTotal-Sharp-Score0-2yrs was 0.01(1.15)(mean(s.d.)). Radiographic progression was observed in nine patients (7%). Successful tapering was independently predicted by: ⩽1 previous bDMARD, male gender, low baseline MRI combined inflammation score or combined damage score. Negative IgM-RF predicted successful discontinuation.

Conclusion: By implementing a clinical guideline, 62% of RA patients in sustained remission in routine care were successfully tapered, including 16% successfully discontinued at 2 years. Radiographic progression was rare. Maximum one bDMARDs, male gender, and low baseline MRI combined inflammation and combined damage scores were independent predictors for successful tapering.

Original languageEnglish
JournalRheumatology (Oxford, England)
Volume58
Issue number1
Pages (from-to)110-119
Number of pages10
ISSN1462-0332
DOIs
Publication statusPublished - 1 Jan 2019

Bibliographical note

COPECARE

    Research areas

  • Aged, Antirheumatic Agents/administration & dosage, Arthritis, Rheumatoid/diagnostic imaging, Biological Products/administration & dosage, Disease Progression, Female, Humans, Induction Chemotherapy, Magnetic Resonance Imaging, Male, Middle Aged, Radiography, Recurrence, Severity of Illness Index, Symptom Flare Up, Time Factors, Treatment Outcome, Withholding Treatment

ID: 59267888